Skip to search formSkip to main contentSkip to account menu

IMVP-16 protocol

Known as: Etoposide/Ifosfamide/Methotrexate, IFF/MTX/VP-16, IMVP-16 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Therapy related myelodysplastic syndrome (t-MDS) and secondary acute myeloid leukemia (AML) are seriously late complications of… 
2009
2009
Hepatosplenic T-cell lymphoma is a rare histologic type of peripheral T-cell lymphoma, which is characterized clinically by… 
2006
2006
Thirty patients with high‐grade malignant lymphoma were treated with ifosfamide‐VP16213‐methotrexate (IMVP‐16) combination… 
Review
2001
Review
2001
Ifosfamide is an alkylating agent with proven efficacy in the treatment of solid tumours and malignant lymphomas. Because it… 
Review
1995
Review
1995
Primary testicular lymphoma (PTL) is the most frequently diagnosed testicular tumor in men over 60 years, in spite of this… 
1994
1994
Peripheral T‐cell lymphomas comprise a heterogenous group of low‐ and high‐grade malignancies differing in their… 
1992
1992
The British National Lymphoma Investigation (BNLI) has assessed the use of an IMVP‐16 regimen (ifosfamide, methotrexate, VP‐16… 
Review
1990
Review
1990
From 1977 to 1989, combination ifosfamide and etoposide has been used at the M.D. Anderson Cancer Center for management of… 
Review
1989
Review
1989
Results of a salvage combination regimen, MIME (methyl-glyoxal-bis-guanylhydrazone [methyl-GAG], ifosfamide, methotrexate…